Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Management of MDR-TB in HIV co-infected patients in eastern europe: results from the TB:HIV study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Increased risk of arterial thromboembolic events after Staphylococcus aureus bacteremia: A matched cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation"

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVES: Mortality among HIV patients with tuberculosis (TB) remains high in Eastern Europe (EE), but details of TB and HIV management remain scarce.

METHODS: In this prospective study, we describe the TB treatment regimens of patients with multi-drug resistant (MDR) TB and use of antiretroviral therapy (ART).

RESULTS: A total of 105 HIV-positive patients had MDR-TB (including 33 with extensive drug resistance) and 130 pan-susceptible TB. Adequate initial TB treatment was provided for 8% of patients with MDR-TB compared with 80% of those with pan-susceptible TB. By twelve months, an estimated 57.3% (95%CI 41.5-74.1) of MDR-TB patients had started adequate treatment. While 67% received ART, HIV-RNA suppression was demonstrated in only 23%.

CONCLUSIONS: Our results show that internationally recommended MDR-TB treatment regimens were infrequently used and that ART use and viral suppression was well below the target of 90%, reflecting the challenging patient population and the environment in which health care is provided. Urgent improvement of management of patients with TB/HIV in EE, in particular for those with MDR-TB, is needed and includes widespread access to rapid TB diagnostics, better access to and use of second-line TB drugs, timely ART initiation with viral load monitoring, and integration of TB/HIV care.

Original languageEnglish
JournalJournal of Infection
Volume76
Issue number1
Pages (from-to)44-54
ISSN0163-4453
DOIs
Publication statusPublished - 2017

    Research areas

  • Journal Article

ID: 51905728